Skip to content

SIGA PHARM

Active
Private limited companyfounded 20233 yrs activeAlsembergsesteenweg 432, 1180 Ukkel, BelgiumKBO/BCE: BE 0801.934.929
Summary

The computed 12-month bankruptcy probability of SIGA PHARM is 4.1% (elevated). The 2024 annual accounts show equity of €29,045 and a net result of €27,045. Its solvency ranks better than 75% of 26034 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€46,193total assets 2024
Equity
€29,045
Profit
€27,045
Turnover not published (abridged schema)
Financial health
50 Fair Checked score 2024
Bankruptcy chance 12 m
4.1%
Structure
Accounts filed 28 d late0 of 1 deed read
Why 50- Figures for FY 2024 (filed 03-09-2025)- Founded in 2023- Size: total assets €46,193- 1 financial year not filed after the legal deadline; latest accounts 28 days lateShow the evidence

Checked score

Score 2024
50 / 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 71% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength
Strong
Solvency 88
equity 62.9% of total assets
Liquidity 43
short-term debt 37.1% · cash 8.3%
Profitability 100
return on assets 58.5%
Bankruptcy probability, 12 months
4.1% Elevated
0%0.5%1.5%4%10%≥ 25%

About 4 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.7% (39,898 companies)
Last 16 months 07-2025: 3.3% 08-2025: 3.3%● 0.0% vs 07-2025 09-2025: 3.3%● 0.0% vs 08-2025 10-2025: 2.3%▼ -31.1% vs 09-2025 11-2025: 2.3%● 0.0% vs 10-2025 12-2025: 2.2%▼ -1.4% vs 11-2025 01-2026: 2.1%▼ -5.4% vs 12-2025 02-2026: 1.9%▼ -8.8% vs 01-2026lowest value 03-2026: 2.0%▲ +0.9% vs 02-2026 04-2026: 2.0%▲ +4.3% vs 03-2026 05-2026: 2.1%▲ +1.2% vs 04-2026 06-2026: 2.0%▼ -1.0% vs 05-2026 07-2026: 2.1%▲ +3.5% vs 06-2026 08-2026: 2.7%▲ +28.6% vs 07-2026 09-2026: 2.9%▲ +8.1% vs 08-2026 10-2026: 4.1%▲ +39.0% vs 09-2026highest value
  • Figures for FY 2024 (filed 03-09-2025) raises the probability
  • Founded in 2023 raises the probability for this profile
  • Size: total assets €46,193 raises the probability for this profile
  • 1 financial year not filed after the legal deadline; latest accounts 28 days late raises the probability
Credit up to €1,000 at 30 days only on tighter terms
Liquidity ample (current ratio 2.55; short-term debt: 37.1% and cash: 8.3% of total assets), and 37.1% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 75%, liquidity 42%, profitability 96%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Figures for FY 2024 (filed 03-09-2025)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Founded in 2023
In the bankruptcy model this factor raises the probability for this profile.
KBO
raises risk · Size: total assets €46,193
In the bankruptcy model this factor raises the probability for this profile.
NBB · annual accounts
raises risk · 1 financial year not filed after the legal deadline; latest accounts 28 days late
In the bankruptcy model this factor raises the probability.
NBB · filings
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-08-2025, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2024
28 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its 2024 accounts 28 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Total assets 2024first fiscal year filed €46,193 View
  • Active since 2023founded 22-05-2023 3 years View

By topic

Financials

Fiscal year
2024
Total assets
€46,193
Profit
€27,045
Solvency
62.9%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
22-05-2023
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.